Objective-To examine the influence of the duration of follow up on the values of heart rate variability (HRV) and the left ventricular ejection fraction (LVEF) for predicting mortality after infarction. Background-HRV is an index of autonomic balance that identifies patients at a high risk of arrhythmic events. The index is most depressed during the first few weeks after myocardial infarction whereas left ventricular function tends to deteriorate with time.
Hypothesis-The value of depressed HRV measured before discharge from hospital for predicting mortality after infarction should decline with time. Methods-The HRV and the LVEF were assessed in 433 survivors of a first acute myocardial infarction: HRV < 20 units and LVEF < 40% were taken as cut off points. Kaplan-Meier survival functions for total cardiac mortality and sudden cardiac death were calculated for the whole five year follow up period and for different intervening periods. Results-During follow up of four weeks to five years there were 46 (10.6%) deaths and 15 (3.5%) patients died suddenly.
Within the whole follow up period, HRV < 20 units and LVEF < 40% were both strongly associated with total cardiac mortality (p < 0*0001), but HRV was an independent predictor of total cardiac mortality only during the first six months of follow up. There were no deaths predicted by HRV < 20 units after the first year of follow up whereas LVEF < 40% had a sensitivity of 43% and a positive predictive accuracy of 90/o for predicting death during this period. HRV < 20 units was better than LVEF < 40%/o in predicting sudden deaths during the first year of follow up but was an independent predictor only of those sudden deaths occurring within six months of infarction.
Conclusions-The duration of follow up affects the prediction of sudden death and total cardiac mortality from HRV.
Reduced HRV as measured before discharge from hospital does not seem to retain independent prognostic value after six months of follow up. These findings have potential implications for the serial evaluation of HRV and for the prevention of sudden death after myocardial infarction.
(Br Heart3J 1994;71:521-527)
The balance between cardiac sympathetic and vagal efferent activity is reflected in beat by beat oscillations of the cardiac cycle.' 2 The magnitude of these oscillations can be assessed by measuring heart rate variability (HRV) from ambulatory electrocardiographic recordings. As sympathetic predominance predisposes to ventricular arrhythmias, whereas vagal stimulation is protective,3 the assessment of HRV provides a means of predicting mortality after myocardial infarction,45 particularly from arrhythmic events.67
The HRV is most obviously depressed during the first few weeks after myocardial infarction,8'0 whereas left ventricular function tends to deteriorate with time, particularly after extensive infarction."1 Therefore, assuming causality between sympathovagal imbalance and mortality, the predictive value of a low HRV measured early after infarction should decline with time; whereas a low LVEF before discharge from hospital should be better for predicting late mortality. The implications of this hypothesis were examined by comparing the HRV and the LVEF as predictors of mortality during different periods of follow up after a first myocardial infarction. The patients were followed up in a clinic dedicated to the care of patients with myocardial infarction with visits at three to four weeks after discharge from hospital, then at three months, and subsequently at least once a year or more often as clinically indicated. Special attention is paid to compliance with medication, the modification of risk factors, such as smoking, hyperlipidaemia, and hypertension, and these were noted at each visit. The main end points of sudden and non-sudden death were classified by a group of physicians without knowledge of the results of risk stratification.
Patients and methods

PATIENTS
As in the cardiac arrhythmia pilot study,14 sudden cardiac death included instantaneous deaths as well as unwitnessed death that occurred within an hour of last being seen alive. The circumstances were determined by interviewing the relatives and the general practitioner. Non sudden cardiac deaths were also defined as in previous studies.'4 STATISTICAL ANALYSIS Results are expressed as mean (SD). Differences between mean values of continuous variables were examined by the Student's t test, and the X2 test with Yates' correction was used for examining the relation between type of infarct, Killip class, thrombolytic treatment, and cardiac mortality during follow up.
Survival data were analysed with the SAS statistical package. Kaplan-Meier survival functions for sudden cardiac death and total cardiac mortality were calculated for the whole five-year follow up period and for the following intervening periods: 0-5 years; 0-1 year; 0-6 months; 6 months-5 years; 6 months-i year; and 1-5 years). The univariate associations between depressed heart rate variability (HRV < 20 units), a low LVEF (LVEF < 40%), and total cardiac mortality and sudden cardiac death during these intervals were examined with the log rank test.
Cox's proportional hazards linear regression was used to determine whether HRV conveyed additional information for the prediction of mortality during the periods of follow up, when LVEF was available. As they are not data from investigations and hence are always available, thrombolytic treatment, /3 blocker treatment, age, and sex were incorporated into all our models examining the possible further contribution of HRV. Thrombolytic treatment, /3 blockade at discharge from hospital, and sex were used as dichotomous variables, whereas age and mean heart rate on Holter monitoring were allowed for in the models as continuous variables. The LVEF was first incorporated into the model and the strength of the marginal association between a depressed HRV index and survival was then inferred from the x2 coefficient statistic score. A p value < 0 05 was considered to be significant.
For ease of interpretation, and because these measures are the most important to clinical practice, the sensitivity and positive predictive accuracy of LVEF and HRV separately and in combination with each other were calculated as indicators of the potential usefulness of the predictions available. (22) units, p = 0-01). Table 2 shows the relation between Killip class in hospital and the HRV and LVEF before discharge .
Results
During a follow up period from four weeks to five years there were 46 (10-6%) deaths and 15 (3 5%) patients died suddenly. Table 5 shows that the HRV < 20 units therefore had a sensitivity of 40% and a positive predictive accuracy of 29% during the first year. An LVEF < 40% had a sensitivity of 48% and positive predictive accuracy of 1 1% during the first year and the presence of either LVEF < 40% or HRV < 20 units increased sensitivity to 64%. After the first year LVEF < 40% had a sensitivity of 43% and a positive predictive accuracy of 9% for predicting total cardiac mortality, but there were no deaths predicted by HRV < 20 units during this period. Table 4 shows the relation between clinical variables and sudden deaths during follow up. Figure 2 represents the association between HRV < 20 units and sudden cardiac death during various periods of follow up. Within the whole follow up period, HRV < 20 units seemed to be more closely associated with sudden cardiac death than was the LVEF < 40%. This association was particularly strong during the first six months after infarction. Compared with LVEF < 40%, HRV < 20 (14) beats/min) in patients discharged from hospital on /3 blockers. Patients with pulmonary congestion or left ventricular failure in hospital were generally excluded from /3 blocker treatment on discharge: only eight (10%) of the 78 patients in Killip class > 1 and two (8%) of the 26 patients in Killip class > 2 were discharged on ,B blockers. None of the 16 patients with Killip class > 1 and who had HRV < 20 were treated with ,B blockers but five (19%) of these 16 patients were discharged on angiotensin converting enzyme inhibitors. Of the 128 patients with mean heart rate < 80 beats/min on Holter monitoring, 64 (50%) were discharged on /3 blockers, compared with 110 (36%) of the 305 patients with a higher mean heart rate (p < 0-01).
UNIVARIATE AND MULTIVARIATE ASSOCIATION BETWEEN LVEF, HRV, AND SUDDEN DEATH DURING DIFFERENT PERIODS OF FOLLOW UP
When /3 blocker treatment was entered into the multivariate model the relation between HRV and cardiac mortality was unaffected.
There was no direct relation between patient compliance with medication during follow up and the main variables examined in the study.
Discussion
The HRV reflects changes in the balance between cardiac sympathetic and vagal efferent activity,12 and its assessment has provided a means of identifying high risk patients after myocardial infarction.45 Our study shows that the HRV index before discharge from hospital is more reliable than the LVEF only for predicting those sudden deaths that occur early after infarction.
Our findings may be explained by a spontaneous improvement in HRV itself. Myocardial infarction is associated with a transient reduction in parasympathetic activity15 16 and HRV shows a similar trend.-'0 This change in sympathovagal balance has been ascribed to activation or interruption of cardiac autonomic reflexes by direct ischaemia or mechanical distortion or disruption of cardiac afferent nerve receptors and to sensory nerve endings lying in an ischaemic milieu.'7 The severity and duration of these changes in autonomic function and whether they are mainly due to reflex activation or interruption may depend on the extent and site of myocardial damage and whether infarction is transmural or non-transmural. 17 These changes coincide with and may be responsible for the high mortality early after myocardial infarction. It has been suggested that the subsequent improvement in sympathovagal balance and HRV and hence in mortality may be due to reversal of ischaemia, the washing out of ischaemic metabolites, receptor necrosis, or to the adaptation of the receptors to continuing mechanical and chemical stimuli.'819 Another potential explanation for our findings could have arisen if patients with low HRV before discharge had been selected for treatment that had then resulted in early mortality. This was not the case as drug treatment, including ,6 blocker, was uncontrolled and clinical management was decided by the referring physician and cardiologist on the basis of the clinical findings, the exercise test, and angiography, but without the results of Holter monitoring. Nevertheless, that the LVEF and HRV were higher and the Killip class lower in patients discharged from hospital on fi blockers does indicate patient selection.
For instance, none of the 16 patients with Killip class > 2 in whom HRV < 20 units were discharged on ,B blockers and only two of these patients were discharged on angiotensin converting enzyme inhibitors. The value of fi blocker treatment or other means of autonomic manipulation early after infarction in this subgroup of patients needs further study.
We found that a low HRV index identified some patients who died but who did not have a low LVEF. One explanation is that myocardial infarction need not be extensive to result either in denervation supersensitivity, which makes the heart more susceptible to arrhythmias,20 or in the selective destruction of inhibitory vagal afferents,2'-2' which would lead to increased efferent sympathetic activity. In other patients a normal LVEF may be maintained by reflex, but potentially deleterious increases in sympathetic drive. Sympathetic predominance in the early period after infarction may also be due to diuretic treatment, sodium restriction in hospital,24 and anxiety.
The association between a low LVEF before discharge and late sudden deaths may be due to a gradual deterioration in left ventricular function consequent on infarct expansion and ventricular remodelling,25 and may well be associated with a fall or an attenuation in the expected rise in HRV in the weeks after myocardial infarction. This needs to be confirmed. Patients with LVEF < 40% were less likely to die suddenly than to die of circulatory failure, whereas patients with HRV < 20 units were more closely associated with sudden death than with all cause mortality, perhaps because the dichotomy point for HRV was designed for predicting arrhythmic events.6 Alternatively, HRV may not become as obviously depressed in patients dying of circulatory failure as it does in those at a high risk of dying suddenly. Another possibility is that HRV may only become noticeably depressed in patients subsequently dying of circulatory failure only after heart failure is clinically apparent.
STUDY LIMITATIONS
A limitation of our study was that serial evaluation of HRV was not undertaken. On the basis of previous studies, however, we think that our assumption that HRV tends to rise after myocardial infarction is correct. Even had serial evaluation of HRV shown that HRV did not change with time this would not have altered our findings with respect to the prognostic value of the HRV before discharge from hospital. Another drawback of our study is the small number of events during each follow up period: but by selecting several overlapping intervals we have shown that the duration of follow up has an important influence on the prediction of sudden death and total cardiac mortality.
CLINICAL IMPLICATIONS
Reduced HRV as measured before discharge from hospital, unlike reduced LVEF, does not seem to have continued significance if the patient survives for six months or longer. The findings provide additional evidence for a causal relation between autonomic dysfunction and sudden death in patients after infarction. 26 The relatively small group of patients with low HRV (8% in our study) may benefit from attention to likely reversible causes of autonomic dysfunction, or provide the basis for prospective studies into the value of prophylactic pharmacological manipulation of autonomic tone.27 The study also shows that about 33% of patients at high risk of sudden death early after infarction may be missed if risk stratification is based solely on the LVEF. Repeat assessment of HRV, however, or other measures of sympathovagal activity after discharge may improve the prediction of late sudden death, particularly in patients with poor left ventricular function. Studies of the relation between the evolution of cardiac function and prognosis after infarction may establish the best time to repeat the investigations. The study also has implications for the planning of prospective double blind studies into the prevention of sudden death after myocardial infarction based on HRV. Such studies should be based on a recent assessment of HRV. The recently published study of captopril in patients with poor left ventricular function after infarction showed that there was no difference in mortality between treated and untreated patients during the first six months of follow up.28 The assessment of HRV before discharge may provide a basis for studies aimed at reducing cardiac mortality during this period.
